Methazolamide NEW
| Price | $48 |
| Package | 500mg |
| Supply Ability: | 10g |
| Update Time: | 2026-06-02 |
Product Details
| Product Name: Methazolamide | CAS No.: 554-57-4 |
| Purity: 99.96% | Supply Ability: 10g |
| Release date: 2026/06/02 |
Product Introduction
Bioactivity
| Name | Methazolamide |
| Description | Methazolamide (CL 8490) is a carbonic anhydrase inhibitor that is used as a diuretic and in the treatment of glaucoma. |
| In vitro | Methazolamide is a carbonic anhydrase inhibitor that inhibits hCA I (Ki: 50 nM), hCA II (Ki: 14 nM) and bCA IV (Ki: 36 nM) isoforms. |
| In vivo | Methazolamide is a carbonic anhydrase inhibitor that inhibits hCA I (Ki: 50 nM), hCA II (Ki: 14 nM) and bCA IV (Ki: 36 nM) isoforms. |
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year Shipping with blue ice/Shipping at ambient temperature. |
| Solubility Information | 10% DMSO+90% Saline : 10 mg/mL (42.32 mM), Solution. H2O : < 1 mg/mL (insoluble or slightly soluble) DMSO : 250 mg/mL (1058.11 mM), Sonication is recommended. Ethanol : 3 mg/mL (12.7 mM), Sonication is recommended. 10% DMSO+40% PEG300+5% Tween 80+45% Saline : 2 mg/mL (8.46 mM), Sonication is recommended. |
| Keywords | pressure-lowering | Methazolamide | L-584601 | L 584601 | intraocular | Inhibitor | inhibit | hCAII | hCAI | glaucoma | disorders | CL-8490 | CL8490 | CarbonicAnhydrase | Carbonic Anhydrase | Carbonate dehydratase | bCAIV |
| Inhibitors Related | Ethoxyquin | Kaolin | Stavudine | Aceglutamide | Allopurinol | Urea | Tamoxifen | Sodium Dihydrogen Phosphate | Metronidazole | Ethyl linoleate | Formamide | Alginic acid |
| Related Compound Libraries | Failed Clinical Trials Compound Library | Bioactive Compound Library | Anti-Cancer Clinical Compound Library | Drug Repurposing Compound Library | Inhibitor Library | Anti-Cancer Approved Drug Library | FDA-Approved Drug Library | Orally Active Compound Library | Immunology/Inflammation Compound Library | Bioactive Compounds Library Max | Anti-Cancer Active Compound Library | Anti-Cancer Drug Library |
Company Profile Introduction
Target Molecule Corp. (TargetMol) is a global high-tech enterprise, headquartered in Boston, MA, specializing in chemical and biological research product and service to meet the research needs of global customers.
TargetMol has evolved into one of the biggest global compound library and small molecule suppliers and a customer based on 40+ countries. TargetMol offers over 80 types of compound libraries and a wide range of high-quality research chemicals including inhibitors, activator, natural compounds, peptides, inhibitory antibodies, and novel life-science kits, for laboratory and scientific use. Besides, virtual screening service is also available for customers who would like to conduct the computer-aided drug discovery.
You may like
Recommended supplier
| Product name | Price | Suppliers | Update time | |
|---|---|---|---|---|
| $48.00 |
VIP2Y
|
TargetMol Chemicals Inc.
|
2026-06-02 | |
| $48.00 |
VIP4Y
|
TargetMol Chemicals Inc.
|
2026-06-02 | |
| $67.00 |
Hebei Fengjia New Material Co., Ltd
|
2025-05-26 | ||
| $9.00 |
Hebei baicao biology science and technology co., ltd
|
2023-02-13 | ||
| $28.99 |
Hong Kong Tiansheng New Material Trading Co., Ltd
|
2022-02-25 | ||
| $15.00 |
Zhuozhou Wenxi import and Export Co., Ltd
|
2021-07-13 | ||
| $7.00 |
VIP8Y
|
Career Henan Chemical Co
|
2019-07-06 | |
| $48.00 |
VIP4Y
|
TargetMol Chemicals Inc.
|
2025-04-27 | |
| $22.00 |
Hong Kong Tiansheng New Material Trading Co., Ltd
|
2022-02-25 | ||
| $15.00 |
Zhuozhou Wenxi import and Export Co., Ltd
|
2021-07-10 |
United States- Since: 2011-01-07
- Address: 36 Washington Street, Wellesley Hill, MA
INQUIRY